Narrow search
Showing 1 - 10 of 64
Cover Image
The effects of state pharmacy drug product selection laws on statin patient generic-to-branded drug switch-backs
Chressanthis, George A.; Dahan, Nayla G.; Fandl, Kevin J. - In: The American economist : journal of Omnicron Delta … 60 (2015) 1, pp. 26-51
Persistent link: https://www.econbiz.de/10011283802
Cover Image
Nonmedical prescription drug use : theory and policy implications
Camera, Gabriele; Engelhardt, Bryan - 2014
Persistent link: https://www.econbiz.de/10010436821
Cover Image
The financial burden of out of pocket prescription drug expenses in Canada
Caldbick, Sam; Wu, Xiaojing; Lynch, Tom; Al-Khatib, Naser; … - In: International journal of health economics and management 15 (2015) 3, pp. 329-338
Persistent link: https://www.econbiz.de/10011473791
Cover Image
Do-it-Yourself Medicine? The Impact of Light Cannabis Liberalization on Prescription Drugs
Carrieri, Vincenzo - 2020
Governments worldwide are increasingly concerned about the booming CBD (cannabidiol) products. However, little is known about the impact of their liberalization. We study a unique case of unintended liberalization of a CBD-based product (light cannabis) that occurred in Italy in 2017. Using...
Persistent link: https://www.econbiz.de/10012839052
Cover Image
How increasing medical access to opioids contributes to the opioid epidemic : evidence from Medicare Part D
Powell, David; Pacula, Rosalie Liccardo; Taylor, Erin - In: Journal of health economics 71 (2020), pp. 1-23
Persistent link: https://www.econbiz.de/10012494181
Cover Image
Preventing drug use
Kilmer, Beau; Pacula, Rosalie Liccardo - In: Targeting investments in children : fighting poverty …, (pp. 181-220). 2010
Persistent link: https://www.econbiz.de/10008810845
Cover Image
The youth online social networking health-risk model : applications for new drug use prevention strategies in Barbados
Jules, Mia Amour - In: The journal of public sector policy analysis 10 (2017), pp. 59-76
Persistent link: https://www.econbiz.de/10011996917
Cover Image
Should we prevent off-label drug prescriptions? : empirical evidence from France
Tunçel, Tuba - 2022
Persistent link: https://www.econbiz.de/10013449336
Cover Image
Strategic submissions: a cross-country analysis of supplemental drug approvals
Dubois, Pierre; Gentry, Elissa Philip; Tuncel, Tuba - 2023
Persistent link: https://www.econbiz.de/10014326955
Cover Image
Does the legalisation of cannabis for medicinal use impact private health insurer prescription drug expenditures?
Cook, Amanda C.; Sirmans, E. Tice; Wells, Brenda - In: The Geneva papers on risk and insurance - issues and … 49 (2024) 1, pp. 212-226
Persistent link: https://www.econbiz.de/10014446859